<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Some autoantibodies have been associated with <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:hpo ids='HP_0000123'>nephritis</z:hpo> but the role of <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> (<z:chebi fb="21" ids="53713">APA</z:chebi>) is controversial </plain></SENT>
<SENT sid="1" pm="."><plain>OBJECTIVE: The present study was to explore the role of <z:chebi fb="21" ids="53713">APA</z:chebi> by comparing demographic profiles and the presence of anticardiolipin antibody (aCL) and <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> (LA) in <z:hpo ids='HP_0002725'>systemiclupus erythematosus</z:hpo> 1 (SLE) patients with and without <z:hpo ids='HP_0000123'>nephritis</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>MATERIAL AND METHOD: The cross-sectional study in a tertiary center was conducted in 77 SLE patients </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients attended our renal or rheumatology clinics between June 2002 and December 2003 </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Sixty-three (82%) of the 77 SLE patients had <z:hpo ids='HP_0000123'>nephritis</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>The prevalence of <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> (APS) was 10% (8 patients), positive aCL (IgG) was 26% (20 patients) and positive LA was 26% (20 patients) </plain></SENT>
<SENT sid="6" pm="."><plain>The receiver operating characteristic (ROC) method was applied to assess the significance of aCL in both <z:hpo ids='HP_0000123'>nephritis</z:hpo> and non-<z:hpo ids='HP_0000123'>nephritis</z:hpo> groups </plain></SENT>
<SENT sid="7" pm="."><plain>Area under the ROC curve was 0.538 (95%CI 0.312-0.765), a cutoff value of 20.5 GPL had a sensitivity of 75% and a specificity of 53% </plain></SENT>
<SENT sid="8" pm="."><plain>In univariate analysis, neither positivity for anticardiolipin antibody nor <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> was associated with <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:hpo ids='HP_0000123'>nephritis</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>Analyzed in only the <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:hpo ids='HP_0000123'>nephritis</z:hpo> group, LA-positive <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:hpo ids='HP_0000123'>nephritis</z:hpo> patients had higher systolic blood pressure (SBP) (133.7 vs 121.9 mmHg, p = 0.005), lower platelet count (209.8 vs 264.4 x 10(3)/microL, p = 0.02) and higher 24-hr urine protein excretion (2.6 vs 1.4 g, p = 0.02) than LA-negative <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:hpo ids='HP_0000123'>nephritis</z:hpo> patients </plain></SENT>
<SENT sid="10" pm="."><plain>Serum <z:chebi fb="0" ids="16737">creatinine</z:chebi> was higher in LA-positive <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:hpo ids='HP_0000123'>nephritis</z:hpo> than LA-negative (233.0 vs 94.9 micromol/L), but did not reach statistical significance </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSION: <z:chebi fb="21" ids="53713">APA</z:chebi> are frequently seen in SLE patients, but not associated with <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:hpo ids='HP_0000123'>nephritis</z:hpo> </plain></SENT>
<SENT sid="12" pm="."><plain>However <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> tends to associate with <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:hpo ids='HP_0000123'>nephritis</z:hpo> </plain></SENT>
<SENT sid="13" pm="."><plain>Detection of LA in <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:hpo ids='HP_0000123'>nephritis</z:hpo> patients could identify patients who had increased risk to develop bad renal outcomes (elevated SBP and 24-hr urine protein excretion) </plain></SENT>
</text></document>